MA56544A - Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci - Google Patents

Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Info

Publication number
MA56544A
MA56544A MA056544A MA56544A MA56544A MA 56544 A MA56544 A MA 56544A MA 056544 A MA056544 A MA 056544A MA 56544 A MA56544 A MA 56544A MA 56544 A MA56544 A MA 56544A
Authority
MA
Morocco
Prior art keywords
pyrolo
pharmaceutically acceptable
acceptable salt
acid ester
phosphoric acid
Prior art date
Application number
MA056544A
Other languages
English (en)
Inventor
Yu KOBAYAKAWA
Hitoshi Miyakoshi
Nozomu Tanaka
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of MA56544A publication Critical patent/MA56544A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
MA056544A 2019-06-18 2020-06-17 Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci MA56544A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019113172 2019-06-18
JP2019157375 2019-08-29

Publications (1)

Publication Number Publication Date
MA56544A true MA56544A (fr) 2022-04-27

Family

ID=74036949

Family Applications (2)

Application Number Title Priority Date Filing Date
MA056544A MA56544A (fr) 2019-06-18 2020-06-17 Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci
MA056546A MA56546A (fr) 2019-06-18 2020-06-17 Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Family Applications After (1)

Application Number Title Priority Date Filing Date
MA056546A MA56546A (fr) 2019-06-18 2020-06-17 Nouveau compose carbonate possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci

Country Status (13)

Country Link
US (2) US20220267365A1 (fr)
EP (2) EP3988174A4 (fr)
JP (2) JP7354245B2 (fr)
KR (2) KR20220015433A (fr)
CN (2) CN114008064A (fr)
AU (2) AU2020298440B2 (fr)
BR (2) BR112021025443A2 (fr)
CA (2) CA3143914A1 (fr)
MA (2) MA56544A (fr)
MX (2) MX2021015973A (fr)
PH (2) PH12021553139A1 (fr)
TW (2) TW202114709A (fr)
WO (2) WO2020255979A1 (fr)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618727C2 (de) * 1996-05-09 2000-02-17 Deutsches Krebsforsch Herstellung alkylierter Nucleosid-3'-Phosphate
WO2004041203A2 (fr) * 2002-11-04 2004-05-21 Xenoport, Inc. Promedicaments de gemcitabine, leurs compositions pharmaceutiques et leurs utilisations
WO2008011406A2 (fr) * 2006-07-18 2008-01-24 Anadys Pharmaceuticals, Inc. Promédicaments à groupes fonctionnels carbonate et carbamate de thiazolo [4,5-d] pyrimidines
PT2231689T (pt) * 2008-01-18 2016-10-07 Inst Of Organic Chemistry And Biochemistry Of The Acad Of Sciences Of The Czech Republic Novos nucleósidos 7-deazapurina citostáticos
EP2393815A4 (fr) * 2009-02-06 2012-11-21 Rfs Pharma Llc Promédicaments à base de purine nucléoside monophosphate pour le traitement du cancer et des infections virales
PT2421879E (pt) * 2009-04-22 2013-12-09 Acad Of Science Czech Republic Novos 7-deazapurina nucleósidos para utilizações terapêuticas
CZ19731U1 (cs) * 2009-04-22 2009-06-15 Tuma@Stanislav Zarízení pro výrobu elektrické energie a tepla z biomasy
WO2013009735A1 (fr) 2011-07-13 2013-01-17 Merck Sharp & Dohme Corp. Dérivés de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales
WO2014124430A1 (fr) * 2013-02-11 2014-08-14 Emory University Compositions thérapeutiques renfermant des nucléotides et des nucléosides et utilisations associées
WO2017165489A1 (fr) 2016-03-23 2017-09-28 Emory University Agents antiviraux pour le traitement d'infections par le le virus zika et de la dengue
US11021510B2 (en) * 2016-11-03 2021-06-01 Laurence I. Wu Prodrugs of clofarabine

Also Published As

Publication number Publication date
TW202114708A (zh) 2021-04-16
JPWO2020255979A1 (fr) 2020-12-24
PH12021553139A1 (en) 2022-07-25
MX2021015973A (es) 2022-02-10
CN113993877A (zh) 2022-01-28
JP7354246B2 (ja) 2023-10-02
EP3988173A4 (fr) 2023-08-02
MA56546A (fr) 2022-04-27
CN114008064A (zh) 2022-02-01
KR20220012349A (ko) 2022-02-03
JPWO2020255978A1 (fr) 2020-12-24
EP3988173A1 (fr) 2022-04-27
BR112021025443A2 (pt) 2022-02-01
CA3143911A1 (fr) 2020-12-24
AU2020295167A1 (en) 2022-02-03
MX2021015772A (es) 2022-01-31
WO2020255979A1 (fr) 2020-12-24
TW202114709A (zh) 2021-04-16
BR112021025341A2 (pt) 2022-02-01
US20220233566A1 (en) 2022-07-28
WO2020255978A1 (fr) 2020-12-24
EP3988174A4 (fr) 2023-04-26
KR20220015433A (ko) 2022-02-08
JP7354245B2 (ja) 2023-10-02
AU2020298440B2 (en) 2023-10-05
CA3143914A1 (fr) 2020-12-24
EP3988174A1 (fr) 2022-04-27
US20220267365A1 (en) 2022-08-25
AU2020298440A1 (en) 2022-01-20
PH12021553143A1 (en) 2022-07-25

Similar Documents

Publication Publication Date Title
EP3924799A4 (fr) Géorepères pour navigation d'uav
IN2014CN03803A (fr)
WO2016012965A3 (fr) Composés d'acide phénylalcanoïque substitué utilisables en tant qu'agonistes de gpr120 et leurs utilisations
NI201200168A (es) Formulaciones farmacéuticas
EP4073036C0 (fr) Forme cristalline d'un dérivé d'acide 7h-benzo[7]annulène-2-carboxylique
WO2011163636A3 (fr) Composés et leurs utilisations dans la modulation des niveaux de différentes alloformes du peptide amyloïde bêta
PL3974441T3 (pl) Związek peptydowy lub jego farmaceutycznie dopuszczalna sól
EP3733648A4 (fr) Procédé de préparation d'acide 5r-benzyloxyaminopipéridin-2s-carboxylique ou d'un dérivé de celui-ci
IL285721A (en) Methods of making high enantioselective secondary alcohols
WO2014159794A3 (fr) Modulateurs de récepteurs gpr120 à base d'acide bicyclo [2.2.1]
WO2016196124A3 (fr) Promédicaments comprenant un lieur de pyroglutamate
MX2024015245A (es) Compuestos utiles como moduladores de la autofagia mediada por chaperonas
MA51606A (fr) Inhibition de synthase d'acide gras (fasn)
CA3275666A1 (en) Crystalline forms of the nrtti compound 4’-ethynyl-2-fluoro-2’- deoxyadenosine
CO2020011860A2 (es) Compuestos de 4–metildihidropirimidinona y su uso farmacéutico
EP3393437C0 (fr) Composition photoprotectrice a base d'un ester d'acide carboxylique; utilisation dudit compose pour augmenter le facteur de protection solaire
EP3421521A4 (fr) Procédé de préparation d'un dérivé de polyéthylène glycol dialdéhyde
MA56544A (fr) Nouveau compose ester d'acide phosphorique possedant un squelette pyrolo-pyrimidine ou sel pharmaceutiquement acceptable de celui-ci
WO2015191681A3 (fr) Pyridinones substituées utilisées comme inhibiteurs de mgat2
IL286692A (en) Crystal form of acid addition salt of furopyrimidine compound
EP3960164A4 (fr) Procédé pour produire une formulation pharmaceutique
EP3591393A4 (fr) Composition pour la détection d'un composé acide
FR3043094B1 (fr) Procede de preparation d'un compose vinylphenolique a partir d'un acide hydroxycinnamique precurseur issu d'un tourteau d'oleagineux
WO2016029216A3 (fr) Procédé de production de dérivés d'amidine
IL291298A (en) Separating a strong acid from its salts